Does erythropoietin treatment of anaemia in chronic renal failure protect the heart?

Maria Wanic-Kossowska

ISSN: 1505-8409

Przewodnik Lekarza/Guide for GPs

Current issue Archive About the journal Supplements Contact Instructions for authors

1/2007
vol. 10

Send email

Copy url:

abstract:

Does erythropoietin treatment of anaemia in chronic renal failure protect the heart?

Maria Wanic-Kossowska

Przew Lek 2007; 1: 34-40

Online publish date: 2007/03/05

View full text Get citation

Anaemia, due to lack of erythropoietin, is a serious complication in patients with chronic kidney disease (CKD). It is known that anaemia is an independent risk factor of mortality in over 60% of patients caused by cardiovascular complications in CKD. Erythropoietin treatment has a beneficial effect on the function and heart structure and prevents progressive development of cardiovascular complications in CKD patients.

keywords:

Does erythropoietin treatment of anaemia in chronic renal failure protect the heart?

Maria Wanic-Kossowska

chronic kidney disease, anaemia, erythropoietin treatment